Results from MINIject’s European STAR-II trial and from the long-term follow-up trial STAR-GLOBAL will feature at the Deutsche Ophthalmologische Gesellschaft (DOG) congress, the annual meeting of the German Ophthalmology Society taking place 30 September to 3 October.
The 18-month data from the European STAR-II trial will be presented on-demand by the global leading ophthalmologist, Professor Burkhard Dick, Head of the University Eye Clinic Bochum, and one of the five German trial centres participating in the study.
Preliminary, interim three-year data from the STAR-GLOBAL study will be revealed in a presentation by Professor Christoph Hirneiss (Ludwig-Maximilians University, Munich, Germany) on Saturday 2nd October at 09:14 on channel 2 in the session “Glaucoma Surgery – Where are we heading?”, followed by live questions and answers.
